On 20th January 2018, Turkey began its military operation called « Olive branch » in Afrin, a city in the north-western part of Syria dominated by the People’s Protection Units (YPG), the mainly-Kurdish militia in the country. Ankara’s goal is to create a 30-kilometer deep safety belt that serves as a buffer zone for its… » read more
Posted by EU-Logos
A scientist working on drug screening is interesting in two things: first, to know whether the drug candidate is effective against cancer cells, and secondly, to understand the way the drug is killing cancer cells.
There is hope indeed, but only for those patients who have enough time to wait. Developing a new drug is an expensive and time-consuming process made even more difficult by today’s global recession.
Professor Rengul Cetin-Atalay is a passionate researcher of Bilkent University’s Genetics and Molecular Biology Department.The researchers at Bilkent University focus on screening possible drug candidates for liver cancer.